Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy

September 14, 2020

EpiPanelDx PLUS adds to Lineagen’s expanding menu of diagnostic tests for children with developmental disorders and provides an offering designed specifically for patients that have experienced seizures or other epilepsy-related symptoms

Read more

New test improves diagnosis of a common genetic cause of autism

October 28, 2019

A new DNA test for Fragile X syndrome has been shown to have accuracy and specificity approaching 100 per cent

Read more

Lineagen and PWNHealth Partner to Expand Access to Genetic Testing Solutions for the Autism Spectrum Disorder and Neurodevelopmental Disorder Communities

January 10, 2019

Lineagen is partnering with PWNHealth to expand access to its clinical genetic tests.

Read more

Michael Paul, Ph.D., CEO of Lineagen, Inc., Nominated for Prestigious Entrepreneur of the Year Award

May 14, 2018

EY (Ernst & Young) Award recognizes entrepreneurs “…whose boldness drives them to do things differently and change our world in the most unexpected ways.”

Read more

Lineagen, Inc. Named to MountainWest Capital Network's 2017 Utah 100

November 8, 2017

Lineagen was named to the 2017 Utah 100, MountainWest Capital Network’s (MWCN) annual list of the fastest-growing companies in Utah.

Read more